Norwegian (OSEAX) Biotech Industry Analysis
UpdatedMay 19, 2024
DataAggregated Company Financials
Companies11
- 7D1.8%
- 3M-44.4%
- 1Y-66.5%
- YTDn/a
Over the last 7 days, the Biotech industry has risen 3.3%, driven by gains from Nykode Therapeutics of 7.8%. Meanwhile, Nordic Nanovector actually underperformed within the industry, shrinking 18% in the last week. In the past year, the industry is down 66%. As for the next few years, earnings are forecast to decline by 9.4% per annum.
Industry Valuation and Performance
Has the Norwegian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 19 May 2024 | kr8.8b | kr638.9m | -kr978,495,264.06 | 31.8x | -9x | 13.7x |
| Tue, 16 Apr 2024 | kr8.5b | kr659.8m | -kr947,531,696.24 | 39.1x | -9x | 13x |
| Thu, 14 Mar 2024 | kr9.1b | kr653.6m | -kr931,171,742.86 | 41.8x | -9.7x | 13.9x |
| Sat, 10 Feb 2024 | kr15.2b | kr658.4m | -kr1,050,354,055.74 | 41.6x | -14.5x | 23.1x |
| Mon, 08 Jan 2024 | kr16.4b | kr654.3m | -kr1,352,819,123.00 | 59.2x | -12.2x | 25.1x |
| Wed, 06 Dec 2023 | kr15.1b | kr663.3m | -kr1,378,930,753.00 | 59.3x | -10.9x | 22.8x |
| Fri, 03 Nov 2023 | kr13.9b | kr492.4m | -kr1,554,375,822.00 | 94.3x | -8.9x | 28.2x |
| Sun, 01 Oct 2023 | kr15.3b | kr624.4m | -kr1,454,603,133.00 | 56.9x | -10.5x | 24.5x |
| Tue, 29 Aug 2023 | kr15.5b | kr627.9m | -kr1,437,682,038.00 | 62.1x | -10.8x | 24.7x |
| Thu, 27 Jul 2023 | kr16.4b | kr554.7m | -kr1,450,357,387.00 | 58.7x | -11.3x | 29.5x |
| Sat, 24 Jun 2023 | kr15.4b | kr563.1m | -kr1,484,688,445.00 | 57.5x | -10.4x | 27.4x |
| Mon, 22 May 2023 | kr16.8b | kr562.1m | -kr1,494,152,506.00 | 61.3x | -11.2x | 29.9x |
| Wed, 19 Apr 2023 | kr16.5b | kr539.4m | -kr1,445,715,757.00 | 30.3x | -11.4x | 30.6x |
| Fri, 17 Mar 2023 | kr15.2b | kr538.9m | -kr1,568,400,283.00 | 30.2x | -9.7x | 28.1x |
| Sun, 12 Feb 2023 | kr18.7b | kr812.7m | -kr1,414,180,896.00 | 33.2x | -13.2x | 23x |
| Tue, 10 Jan 2023 | kr18.5b | kr807.4m | -kr1,393,407,216.00 | 28x | -13.3x | 22.9x |
| Thu, 08 Dec 2022 | kr18.2b | kr814.1m | -kr1,396,956,363.00 | 37.5x | -13.1x | 22.4x |
| Sat, 05 Nov 2022 | kr17.4b | kr805.0m | -kr1,365,212,267.00 | 36.1x | -12.8x | 21.7x |
| Mon, 03 Oct 2022 | kr16.3b | kr823.6m | -kr1,367,968,157.00 | 36.4x | -11.9x | 19.8x |
| Wed, 31 Aug 2022 | kr20.8b | kr784.7m | -kr1,378,017,087.00 | 36.4x | -15.1x | 26.4x |
| Fri, 29 Jul 2022 | kr19.6b | kr768.4m | -kr1,380,660,609.00 | 43.4x | -14.2x | 25.5x |
| Sun, 26 Jun 2022 | kr19.9b | kr769.5m | -kr1,380,979,565.00 | 43.1x | -14.4x | 25.9x |
| Tue, 24 May 2022 | kr22.7b | kr1.1b | -kr1,032,414,352.00 | 38.7x | -22x | 20.8x |
| Thu, 21 Apr 2022 | kr25.3b | kr1.0b | -kr985,741,044.00 | 41.9x | -25.6x | 24.3x |
| Sat, 19 Mar 2022 | kr26.9b | kr2.7b | kr392.6m | 10.2x | 68.4x | 10.1x |
| Mon, 14 Feb 2022 | kr29.6b | kr2.7b | kr447.4m | 11x | 66.2x | 11.1x |
| Wed, 12 Jan 2022 | kr38.5b | kr2.2b | kr43.6m | 38.5x | 884.1x | 17.6x |
| Fri, 10 Dec 2021 | kr38.9b | kr2.2b | kr76.2m | 42.3x | 510.8x | 17.4x |
| Sun, 07 Nov 2021 | kr36.7b | kr2.6b | kr471.0m | 14.6x | 78x | 14.3x |
| Tue, 05 Oct 2021 | kr37.7b | kr2.6b | kr479.3m | 15x | 78.6x | 14.7x |
| Thu, 02 Sep 2021 | kr39.7b | kr2.6b | kr508.1m | 17.5x | 78.2x | 15.4x |
| Sat, 31 Jul 2021 | kr35.8b | kr2.6b | kr508.1m | 13.9x | 70.5x | 13.9x |
Price to Earnings Ratio
77.6x
Current Industry PE
- Investors are pessimistic on the Norwegian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 21.4x is higher than the industry's current PS ratio of 13.9x.
Past Earnings Growth
- Total earnings for the Biotechnology industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 37% per year, which is driving profits down.
Industry Comparison
How does Norwegian Biotech compare with similar industries?
| NO Market | -1.02% | |
| Healthcare | 2.71% | |
| Biotech | 1.78% | |
| Biotech | 1.78% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NYKD Nykode Therapeutics | kr14.67 | 4.5% +kr205.7m | -44.0% | PS40.7x | |
| ULTI Ultimovacs | kr7.35 | 6.1% +kr14.5m | -94.1% | PB1x | |
| LYTIX Lytix Biopharma | kr5.60 | 2.2% +kr4.8m | -41.7% | PS21.9x | |
| PCIB PCI Biotech Holding | kr1.63 | 1.9% +kr1.1m | -14.1% | PS20.3x |